Pomalidomide Impurity 15 | CAS 26581-81-7 - Request Quote
Pomalidomide Impurity 15
| SZ CAT No: | SZ-P055031 |
| CAS No | 26581-81-7 |
| Mol.F. | C13H12N2O3 |
| Mol.Wt. | 244.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Usage Note:
Pomalidomide Impurity 15 is chemically 3-(1-Oxoisoindolin-2-yl)piperidine-2,6-dione. Pomalidomide Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Pomalidomide Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pomalidomide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 26581-81-7
Purchase 26581-81-7
Order 26581-81-7
Enquire 26581-81-7
price of 26581-81-7
26581-81-7 Supplier
26581-81-7 Manufacturer
26581-81-7 Exporter
buy high quality Pomalidomide Impurity 15
Purchase Pomalidomide Impurity 15
Pomalidomide Impurity 15 suppliers
Pomalidomide Impurity 15 manufacturers
Pomalidomide Impurity 15 price
Order Pomalidomide Impurity 15
Enquire Pomalidomide Impurity 15
Pomalidomide Impurity 15 cost
Pomalidomide Impurity 15 Supplier
Pomalidomide Impurity 15 Distributor
Pomalidomide Impurity 15 for Method Validation
Pomalidomide Reference Standard
Pomalidomide Impurity 15 for ANDA Filing
Pomalidomide Impurity 15 for Forced Degradation Studies
Pomalidomide Impurity 15 Identification Standards
Pomalidomide Impurity 15 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


